Avid Bioservices Inc (CDMO)

[jakedogman1]

I'm having a problem understanding what is going on. I just watched the bavi video again; I just looked at the SRB; I looked at the press releases over the last year; I did some research on sales of companies with Mab's under development and I just looked at the stock price. The market is telling us that the Cotara and Bavi drugs and all other preclinical stuff and patents are worth about $30 mil after deducting the cash and value for Avid. Can the company sell this pipeline for more than this right now? I'd say yes. Is R&R working to benefit pphm shareholder? I'd say no (most likely to benefit themselves by placing dark clouds) and working for their clients.

Either Bavi and Cotara potential are what mgmt and R&R say they are and we should be trading much higher or someone is sandbagging for their benefit which I think is mgmt and R&R. The question I have is why is mgmt letting R&R drum up demand when it's obvious things are not happening. If the story is so compelling (which I think it is), why isn't mgmt getting in front of folks to tell the story. It would only take one, perhaps two or more wealthy folks to see the value and invest. And for many in that crowd, it would be chump change. With all the contacts thru the UT system, Komen Foundation, Sammons, Duke, this would appear to be an easy task. It's obviously not happening. IMO mgmt has been led down the offshore PIPE road by a board member that possibly benefits from the financings. It may have been the best alternative years ago when bavi was just getting started. I don't believe that's the case now.

This is why I think change needs to happen and soon. My patience is running out.